PUFAs regulate SREBP1c through phosphorylation of Insig2
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2416363121 ↗Kurz gefasst
Kommentar in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Xu Xiao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA 90095. Hauptthemen laut MEDLINE: Sterol Regulatory Element Binding Protein 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The synthesis of fatty acids in mammalian liver is controlled in large measure by the transcription factor sterol regulatory element - binding protein 1c (SREBP1c). During activation, membrane - bound SREBP1c is transported from endoplas - micreticulum (ER) to Golgi and processed proteolytically to release the mature transcription factor. Mature SREBP1c moves to the nucleus where it binds the promoters of a bat - tery of genes needed for lipid synthesis ( 1 ). Prior studies have shown that Polyunsaturatedfatty acids (PUFAs) inhibit the SERBP1c pathway at both the mRNA (messenger RNA) and protein levels to regulate lipogenesis ( 2 ). Transcriptional con - trol of SREBP1c gene expression is known to involve several factors, including LXRs (liver X receptors), C/EBPs (CAAT - enhancer binding proteins), and BHLHE40 ( 3 ). The mecha - nism underlying the ability of PUFAs to affect SREBP1c proteolytic processing has been less clear. Tian et al. provide important insight by demonstrating that PUFAs suppress lipogenesis through cAMP (cyclic AMP)/PKA (protein kinase A) - dependent phosphorylation of the ER protein Insig2 ( 4 ). Tian et al. used a human fibroblast model to study PUFA effects on the SREBP1c pathway. They first demonstrated that PUFAs decreased SREBP1c cleavage in a dose - and time - dependent manner, with only minor reductions in mRNA levels. Prior work has shown that PUFA treatment induces cAMP levels and activate PKA in myocytes and 3T3 - L1 cells ( 5 , 6 ). Tian et al. found similar results in human fibroblasts. They further showed that activation of PKA with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA 90095.
- Department of Biological Chemistry, University of California, Los Angeles, CA 90095.
ORCID-Profile: Xu Xiao, Peter Tontonoz
Zitieren
APA
Xiao, X., & Tontonoz, P. (2024). PUFAs regulate SREBP1c through phosphorylation of Insig2. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2416363121
Vancouver
Xiao X, Tontonoz P. PUFAs regulate SREBP1c through phosphorylation of Insig2. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2416363121
BibTeX
@article{Xiao2024,
author = {Xiao, Xu and Tontonoz, Peter},
title = {PUFAs regulate SREBP1c through phosphorylation of Insig2},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2416363121}
}
EUVIMED